First Time Loading...

Medacta Group SA
SIX:MOVE

Watchlist Manager
Medacta Group SA Logo
Medacta Group SA
SIX:MOVE
Watchlist
Price: 111.4 CHF 0.36% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

Medacta Group SA engages in the development, manufacture, and distribution of orthopedic and neurosurgical medical devices. [ Read More ]

The intrinsic value of one MOVE stock under the Base Case scenario is 127.14 CHF. Compared to the current market price of 111.4 CHF, Medacta Group SA is Undervalued by 12%.

Key Points:
MOVE Intrinsic Value
Base Case
127.14 CHF
Undervaluation 12%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Medacta Group SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling MOVE stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Medacta Group SA

Provide an overview of the primary business activities
of Medacta Group SA.

What unique competitive advantages
does Medacta Group SA hold over its rivals?

What risks and challenges
does Medacta Group SA face in the near future?

Summarize the latest earnings call
of Medacta Group SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medacta Group SA.

Provide P/S
for Medacta Group SA.

Provide P/E
for Medacta Group SA.

Provide P/OCF
for Medacta Group SA.

Provide P/FCFE
for Medacta Group SA.

Provide P/B
for Medacta Group SA.

Provide EV/S
for Medacta Group SA.

Provide EV/GP
for Medacta Group SA.

Provide EV/EBITDA
for Medacta Group SA.

Provide EV/EBIT
for Medacta Group SA.

Provide EV/OCF
for Medacta Group SA.

Provide EV/FCFF
for Medacta Group SA.

Provide EV/IC
for Medacta Group SA.

Show me price targets
for Medacta Group SA made by professional analysts.

What are the Revenue projections
for Medacta Group SA?

How accurate were the past Revenue estimates
for Medacta Group SA?

What are the Net Income projections
for Medacta Group SA?

How accurate were the past Net Income estimates
for Medacta Group SA?

What are the EPS projections
for Medacta Group SA?

How accurate were the past EPS estimates
for Medacta Group SA?

What are the EBIT projections
for Medacta Group SA?

How accurate were the past EBIT estimates
for Medacta Group SA?

Compare the revenue forecasts
for Medacta Group SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Medacta Group SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medacta Group SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medacta Group SA compared to its peers.

Compare the P/E ratios
of Medacta Group SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Medacta Group SA with its peers.

Analyze the financial leverage
of Medacta Group SA compared to its main competitors.

Show all profitability ratios
for Medacta Group SA.

Provide ROE
for Medacta Group SA.

Provide ROA
for Medacta Group SA.

Provide ROIC
for Medacta Group SA.

Provide ROCE
for Medacta Group SA.

Provide Gross Margin
for Medacta Group SA.

Provide Operating Margin
for Medacta Group SA.

Provide Net Margin
for Medacta Group SA.

Provide FCF Margin
for Medacta Group SA.

Show all solvency ratios
for Medacta Group SA.

Provide D/E Ratio
for Medacta Group SA.

Provide D/A Ratio
for Medacta Group SA.

Provide Interest Coverage Ratio
for Medacta Group SA.

Provide Altman Z-Score Ratio
for Medacta Group SA.

Provide Quick Ratio
for Medacta Group SA.

Provide Current Ratio
for Medacta Group SA.

Provide Cash Ratio
for Medacta Group SA.

What is the historical Revenue growth
over the last 5 years for Medacta Group SA?

What is the historical Net Income growth
over the last 5 years for Medacta Group SA?

What is the current Free Cash Flow
of Medacta Group SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Medacta Group SA.

Financials

Balance Sheet Decomposition
Medacta Group SA

Current Assets 348.5m
Cash & Short-Term Investments 27.8m
Receivables 106.7m
Other Current Assets 213.9m
Non-Current Assets 347.4m
Long-Term Investments 712k
PP&E 267.3m
Intangibles 51.4m
Other Non-Current Assets 27.9m
Current Liabilities 149.4m
Accounts Payable 38.9m
Accrued Liabilities 40.2m
Other Current Liabilities 70.4m
Non-Current Liabilities 216.4m
Long-Term Debt 148.2m
Other Non-Current Liabilities 68.2m
Efficiency

Earnings Waterfall
Medacta Group SA

Revenue
510.8m EUR
Cost of Revenue
-162.9m EUR
Gross Profit
347.8m EUR
Operating Expenses
-272.1m EUR
Operating Income
75.7m EUR
Other Expenses
-28.4m EUR
Net Income
47.4m EUR

Free Cash Flow Analysis
Medacta Group SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

MOVE Profitability Score
Profitability Due Diligence

Medacta Group SA's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
60/100
Profitability
Score

Medacta Group SA's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

MOVE Solvency Score
Solvency Due Diligence

Medacta Group SA's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
High Interest Coverage
Short-Term Solvency
67/100
Solvency
Score

Medacta Group SA's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MOVE Price Targets Summary
Medacta Group SA

Wall Street analysts forecast MOVE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOVE is 146.46 CHF with a low forecast of 131.3 CHF and a high forecast of 161.7 CHF.

Lowest
Price Target
131.3 CHF
18% Upside
Average
Price Target
146.46 CHF
31% Upside
Highest
Price Target
161.7 CHF
45% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

MOVE Price
Medacta Group SA

1M 1M
-9%
6M 6M
+7%
1Y 1Y
-1%
3Y 3Y
-4%
5Y 5Y
+17%
10Y 10Y
+17%
Annual Price Range
111.4
52w Low
99.6
52w High
134
Price Metrics
Average Annual Return 8.35%
Standard Deviation of Annual Returns 42.99%
Max Drawdown -53%
Shares Statistics
Market Capitalization 2.2B CHF
Shares Outstanding 19 957 500
Percentage of Shares Shorted
N/A

MOVE Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Medacta Group SA Logo
Medacta Group SA

Country

Switzerland

Industry

Health Care

Market Cap

2.2B CHF

Dividend Yield

0.49%

Description

Medacta Group SA engages in the development, manufacture, and distribution of orthopedic and neurosurgical medical devices. The company is headquartered in Castel San Pietro, Ticino and currently employs 1,341 full-time employees. The company went IPO on 2019-04-04. The firm develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The firm designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.

Contact

TICINO
Castel San Pietro
Strada Regina 34

IPO

2019-04-04

Employees

1 341

Officers

Founder & Non Executive Chairman
Dr. Alberto Siccardi
Chief Executive Officer
Dr. Francesco Siccardi
Chief Financial Officer
Mr. Corrado Farsetta
Senior Director of Global Marketing
Gianluca Olgiati
Chief People Officer
Asif Hussain
Chief Supply Chain Officer
Mr. Alessandro Siccardi
Show More
Head of IT
Filippo Cappelli
Chief Commercial Officer
Giovanni Niccolo Galli
Chief Innovation Officer
Massimiliano Bernardoni
Secretary of the Board
Donato Cortesi
Show Less

See Also

Discover More
What is the Intrinsic Value of one MOVE stock?

The intrinsic value of one MOVE stock under the Base Case scenario is 127.14 CHF.

Is MOVE stock undervalued or overvalued?

Compared to the current market price of 111.4 CHF, Medacta Group SA is Undervalued by 12%.